Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
Lyell Immunopharma (LYEL) Ownership - Who Owns Lyell Immunopharma?
57 Followers
Lyell Immunopharma (LYEL) Ownership Overview
44.24% Insiders
11.78% Mutual Funds
9.52% Other Institutional Investors
34.46% Public Companies and
Individual Investors
The ownership structure of Lyell Immunopharma (LYEL) stock is a mix of institutional, retail and individual investors. Approximately 21.31% of the company’s stock is owned by Institutional Investors, 44.24% is owned by Insiders and 34.46% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 17, 2023 | Richard Klausner Director | Sold | $132286 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $50185 | |
| Dec 31, 2023 | Sold | $73809 | |
| Dec 31, 2023 | Bought | $127328 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,932,877 | Institution | 5.09% | 31,038,905 | |
| 12,003,606 | Institution | 4.72% | 28,808,654 | |
| 8,384,175 | Institution | 3.30% | 20,122,020 | |
| 5,045,778 | Institution | 1.99% | 12,109,867 | |
| 1,912,644 | Institution | 0.75% | 4,590,346 | |
| 1,634,056 | Institution | 0.64% | 3,921,734 | |
| 1,618,575 | Institution | 0.64% | 3,884,580 | |
| 1,486,286 | Institution | 0.58% | 3,567,086 | |
| 886,731 | Institution | 0.35% | 2,128,154 | |
| 831,422 | Institution | 0.33% | 1,995,413 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,003,606 | Institution | 4.72% | 28,808,654 | |
| 5,045,778 | Institution | 1.99% | 12,109,867 | |
| 1,912,644 | Institution | 0.75% | 4,590,346 | |
| 1,634,056 | Institution | 0.64% | 3,921,734 | |
| 1,618,575 | Institution | 0.64% | 3,884,580 | |
| 1,486,286 | Institution | 0.58% | 3,567,086 | |
| 886,731 | Institution | 0.35% | 2,128,154 | |
| 679,921 | Institution | 0.27% | 1,631,810 | |
| 676,627 | Institution | 0.27% | 1,623,905 | |
| 601,590 | Institution | 0.24% | 1,443,816 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,817,818 | Institution | 2.29% | 12,973,734 | |
| 4,218,964 | Institution | 1.66% | 10,125,514 | |
| 2,391,088 | Institution | 0.94% | 5,332,126 | |
| 2,243,636 | Institution | 0.88% | 5,003,308 | |
| 1,628,226 | Institution | 0.64% | 3,907,742 | |
| 1,273,209 | Institution | 0.50% | 2,839,256 | |
| 753,290 | Institution | 0.30% | 2,267,403 | |
| 852,310 | Institution | 0.34% | 2,045,544 | |
| 651,911 | Institution | 0.26% | 1,453,762 | |
| 424,864 | Institution | 0.17% | 947,447 |
FAQ
Who Owns Lyell Immunopharma (LYEL)?
According to the latest TipRanks data, approximately 9.52% of the company's stock is held by institutional investors, 44.24% is held by insiders, and 34.46% is held by retail investors.
What percentage of Lyell Immunopharma (LYEL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.52% of Lyell Immunopharma (LYEL) stock is held by institutional investors.
What percentage of Lyell Immunopharma (LYEL) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.46% of Lyell Immunopharma (LYEL) stock is held by retail investors.
Who owns the most shares of Lyell Immunopharma (LYEL)?
Vanguard owns the most shares of Lyell Immunopharma (LYEL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.